Although these results together suggest potential importance of ADARB2 in the molecular pathology of AD, the high inter-individual variance and relatively small within-pair differences in blood suggest that methylation at this region alone is unlikely to have value as a diagnostic marker. The gene discussed is ADARB2; the disease is Alzheimer disease.